Your browser doesn't support javascript.
loading
Biomimetic Nanodisks Are Effective Against Tubulointerstitial Fibrosis via Targeting Interstitial Microenvironment.
Zhou, Chuchu; Tang, Rou; Tan, Huajin; Yang, Yige; Meng, Peipei; Li, He; Song, Kaichao; Tan, Xiaochuan; Guo, Xiuping; Ren, Ling; He, Shuwang; Meng, Ya; Hao, Yumei; Lin, Mingbao; Zhang, Yujia; Huang, Hongdong; Wang, Lulu; Zheng, Wensheng.
Afiliação
  • Zhou C; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica (C.Z., R.T., H.T., Y.Y., K.S., X.T., Y.M., Y.H., M.L., Y.Z., W.Z.), Chinese Academy of Medical Sciences and Peking Unio
  • Tang R; Clinical Research Center, Beijing Children's Hospital, National Center for Children's Health (C.Z.), Capital Medical University, China.
  • Tan H; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica (C.Z., R.T., H.T., Y.Y., K.S., X.T., Y.M., Y.H., M.L., Y.Z., W.Z.), Chinese Academy of Medical Sciences and Peking Unio
  • Yang Y; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica (C.Z., R.T., H.T., Y.Y., K.S., X.T., Y.M., Y.H., M.L., Y.Z., W.Z.), Chinese Academy of Medical Sciences and Peking Unio
  • Meng P; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica (C.Z., R.T., H.T., Y.Y., K.S., X.T., Y.M., Y.H., M.L., Y.Z., W.Z.), Chinese Academy of Medical Sciences and Peking Unio
  • Li H; Department of Nephrology, Beijing Friendship Hospital, Faculty of Kidney Diseases (P.M., H.H.), Capital Medical University, China.
  • Song K; Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing (P.M.).
  • Tan X; Beijing Tiantan Hospital (H.L.), Capital Medical University, China.
  • Guo X; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica (C.Z., R.T., H.T., Y.Y., K.S., X.T., Y.M., Y.H., M.L., Y.Z., W.Z.), Chinese Academy of Medical Sciences and Peking Unio
  • Ren L; Institute of Medicinal Biotechnology (K.S., X.G., L.R., L.W.), Chinese Academy of Medical Sciences and Peking Union Medical College, China.
  • He S; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica (C.Z., R.T., H.T., Y.Y., K.S., X.T., Y.M., Y.H., M.L., Y.Z., W.Z.), Chinese Academy of Medical Sciences and Peking Unio
  • Meng Y; Institute of Medicinal Biotechnology (K.S., X.G., L.R., L.W.), Chinese Academy of Medical Sciences and Peking Union Medical College, China.
  • Hao Y; Institute of Medicinal Biotechnology (K.S., X.G., L.R., L.W.), Chinese Academy of Medical Sciences and Peking Union Medical College, China.
  • Lin M; Shandong DYNE Marine Biopharmaceutical Co, Ltd, Rongcheng, China (S.H.).
  • Zhang Y; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica (C.Z., R.T., H.T., Y.Y., K.S., X.T., Y.M., Y.H., M.L., Y.Z., W.Z.), Chinese Academy of Medical Sciences and Peking Unio
  • Huang H; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica (C.Z., R.T., H.T., Y.Y., K.S., X.T., Y.M., Y.H., M.L., Y.Z., W.Z.), Chinese Academy of Medical Sciences and Peking Unio
  • Wang L; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica (C.Z., R.T., H.T., Y.Y., K.S., X.T., Y.M., Y.H., M.L., Y.Z., W.Z.), Chinese Academy of Medical Sciences and Peking Unio
  • Zheng W; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica (C.Z., R.T., H.T., Y.Y., K.S., X.T., Y.M., Y.H., M.L., Y.Z., W.Z.), Chinese Academy of Medical Sciences and Peking Unio
Circ Res ; 135(6): e150-e153, 2024 Aug 30.
Article em En | MEDLINE | ID: mdl-39092524
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose / Materiais Biomiméticos Limite: Animals / Humans Idioma: En Revista: Circ Res / Circ. res / Circulation research Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose / Materiais Biomiméticos Limite: Animals / Humans Idioma: En Revista: Circ Res / Circ. res / Circulation research Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos